Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| 1 |
Merck
MRK
|
+$921M |
| 2 |
Union Pacific
UNP
|
+$581M |
| 3 |
Salesforce
CRM
|
+$417M |
| 4 |
Edwards Lifesciences
EW
|
+$409M |
| 5 |
ServiceNow
NOW
|
+$316M |
Top Sells
| 1 |
Caterpillar
CAT
|
+$664M |
| 2 |
RHT
Red Hat Inc
RHT
|
+$632M |
| 3 |
Texas Instruments
TXN
|
+$571M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$540M |
| 5 |
Parker-Hannifin
PH
|
+$513M |
Sector Composition
| 1 | Technology | 21.1% |
| 2 | Healthcare | 17.5% |
| 3 | Consumer Discretionary | 17.06% |
| 4 | Financials | 12.7% |
| 5 | Communication Services | 11.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
451
Clearway Energy Class A
CWEN.A
$3.18B
| $8.44M | 0.01% |
498,852
+517
| +0.1% | +$8.75K |
|
452
Box
BOX
$4.74B
| $8.41M | 0.01% |
497,912
-36,475
| -7% | -$616K |
|
|
AXE
453
DELISTED
Anixter International Inc
AXE
| $8.11M | 0.01% |
149,227
-114,270
| -43% | -$6.21M |
|
454
Apellis Pharmaceuticals
APLS
$3.29B
| $7.74M | 0.01% |
586,924
+12,065
| +2% | +$159K |
|
|
RUBY
455
DELISTED
Rubius Therapeutics, Inc
RUBY
| $7.68M | 0.01% |
477,596
+5,387
| +1% | +$86.6K |
|
|
TVTY
456
DELISTED
Tivity Health, Inc. Common Stock
TVTY
| $7.68M | 0.01% |
309,497
-408,874
| -57% | -$10.1M |
|
457
Kosmos Energy
KOS
$832M
| $7.57M | 0.01% |
1,859,873
+492,290
| +36% | +$2M |
|
|
WES
458
DELISTED
Western Gas Partners Lp
WES
| $7.57M | 0.01% |
+179,233
| New | +$7.57M |
|
|
ANDX
459
DELISTED
Andeavor Logistics LP
ANDX
| $7.54M | 0.01% |
231,995
-10,871
| -4% | -$353K |
|
460
Wheaton Precious Metals
WPM
$47.9B
| $7.46M | 0.01% |
382,016
-65,847
| -15% | -$1.29M |
|
461
Chemours
CC
$2.44B
| $7.23M | 0.01% |
256,031
-36,912
| -13% | -$1.04M |
|
|
NBLX
462
DELISTED
Noble Midstream Partners LP
NBLX
| $7.19M | 0.01% |
249,218
-11,677
| -4% | -$337K |
|
463
Alcoa
AA
$8.01B
| $6.61M | 0.01% |
248,786
-51,978
| -17% | -$1.38M |
|
|
CEQP
464
DELISTED
Crestwood Equity Partners LP
CEQP
| $6.58M | 0.01% |
235,714
-11,043
| -4% | -$308K |
|
465
Insulet
PODD
$23.8B
| $6.57M | 0.01% |
82,820
+79,234
| +2,210% | +$6.28M |
|
466
Ocular Therapeutix
OCUL
$2.27B
| $6.5M | 0.01% |
1,632,646
-703,343
| -30% | -$2.8M |
|
|
WBT
467
DELISTED
Welbilt, Inc.
WBT
| $6.5M | 0.01% |
584,786
+4,908
| +0.8% | +$54.5K |
|
468
Hudbay
HBM
$5.33B
| $6.48M | 0.01% |
1,368,195
-97,259
| -7% | -$460K |
|
469
Constellium
CSTM
$2.02B
| $6.38M | 0.01% |
913,318
-116,682
| -11% | -$816K |
|
470
Warrior Met Coal
HCC
$3.08B
| $6.29M | 0.01% |
260,759
-17,092
| -6% | -$412K |
|
471
AnaptysBio
ANAB
$637M
| $6.15M | 0.01% |
96,400
-2,193
| -2% | -$140K |
|
|
SEI
472
Solaris Energy Infrastructure, Inc.
SEI
$1.31B
| $5.99M | 0.01% |
495,223
-33,522
| -6% | -$405K |
|
473
Heron Therapeutics
HRTX
$195M
| $5.96M | 0.01% |
229,626
+2,575
| +1% | +$66.8K |
|
474
Kodiak Sciences
KOD
$514M
| $5.66M | 0.01% |
+797,423
| New | +$5.66M |
|
475
Celanese
CE
$4.84B
| $5.62M | 0.01% |
62,509
-357,445
| -85% | -$32.2M |
|